奇托桑-酸微囊:一种提高牛乳酸稳定性和抗菌潜力的策略
Agustina Cots1, Nahuel Matías Camacho2, Santiago Daniel Palma2
1Instituto de Ciencias Veterinarias, Consejo Nacional de Investigaciones Científicas y Técnicas (INCIVET, CONICET), Universidad Nacional de Río Cuarto (UNRC), Río Cuarto 5800, Córdoba, Argentina.
International journal of biological macromolecules
|March 12, 2025
概括
奇托/阿尔金酸盐微粒保护口服乳酸免受胃部降解,增强其稳定性和对大肠杆菌的抗菌功效. 这种新的输送系统可以改善乳托费林.
科学领域:
- 生物材料科学 生物材料科学
- 药物运输 药物运输 药物运输
- 微生物学 微生物学
背景情况:
- 口服乳酸显示出感染性疾病治疗的潜力,但由于胃部降解,其生物利用性较差.
- 提高乳费林的稳定性和输送对于其治疗应用至关重要.
研究的目的:
- 开发和描述用于口服Lactoferrin输送的奇托桑/阿尔金酸盐微粒.
- 为了评估这些微粒中封装的乳费林的稳定性,释放特征和抗菌活性.
主要方法:
- 通过外部离子凝合成的奇托/酸盐微粒.
- 使用FT-IR光谱,泽塔电位分析和在模拟胃肠道液体中的释放研究进行了表征.
- 针对大肠杆菌的抗菌分析.
主要成果:
- 微粒呈现出高的Lactoferrin加载效率 (93.65%) 和小尺寸.
- 封装的乳酸显示在模拟的胃和肠液中稳定性提高.
- 奇托桑/阿尔金酸盐微囊保留了拉克托费林对大肠杆菌的抗菌活性.
- 作用机制涉及通过LPS相互作用破坏细菌膜的稳定.
结论:
- 奇托/阿尔金酸盐微粒是口服乳酸输送的有希望的策略.
- 这种系统增强了乳酸的稳定性,生物可用性和治疗潜力.
- 进一步的研究可以探索这个系统的其他治疗蛋白质.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


